ArticleThe FEBS journal2025
Crystal structure and biophysical characterisation of the enterococcal foldase PpiC, a cross-opsonic antigen against gram-positive nosocomial pathogens.
Article in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Enterococcus faecium have high rates of antibiotic resistances, with vancomycin-resistant E. faecium acknowledged as the most important in the clinical setting and declared by WHO to be a threat to humankind, for which rapid actions are needed. PpiC is a membrane-bound lipoprotein of E. faecium endowed with both a peptidyl-prolyl isomerase and a foldase activity, and plays a key role in assisting the folding of many secreted enterococcal proteins. It is located at the membrane-wall interface, therefore easily accessible to inhibitors and to the immune system and an ideal target for drug and vaccine development. Despite their potential, enterococcal peptidyl-prolyl isomerases have been understudied. We previously identified PpiC as an important cross-protective vaccine antigen. To gain a better understanding of the PpiC biological role in E. faecium survival, we determined the crystal structure of PpiC and investigated its biophysical properties. Consistent with PpiC's folding activity, the biological assembly of PpiC is a bowl-shaped structure containing two parvulin-type peptidyl-prolyl cis/trans isomerase domains. We also dissected the role of N- and C-terminal regions of the molecule in its dimerisation, an event which is predicted to play an important role in the folding of client proteins. Our data point to a functional cross-talk between the foldase and peptidyl-prolyl isomerase activities of PpiC, through the protein-swapping involved in dimerisation. Also, our work provides key structural data for the design of antimicrobials and cross-protective vaccine antigens against nosocomial infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.